Copyright
©The Author(s) 2022.
World J Clin Cases. Aug 16, 2022; 10(23): 8097-8106
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8097
Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8097
Table 2 Type, dose and number of patients on nonselective or selective beta-blockers
| Number of patients | Total daily dose (mg) | |
| Nonselective beta-blocker (n = 143) | ||
| Nadolol | 66 (46.2) | 20 (20-80) |
| Propranolol | 62 (43.4) | 30 (10-80) |
| Carvedilol | 15 (10.5) | 12.50 (6.25-50.00) |
| Selective beta-blocker (n = 39) | ||
| Metoprolol | 35 (89.7) | 50.00 (12.50-200.00) |
| Atenolol | 4 (10.3) | 50 (25-100) |
- Citation: Fallahzadeh MA, Asrani SK, Tapper EB, Saracino G, Rahimi RS. Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis. World J Clin Cases 2022; 10(23): 8097-8106
- URL: https://www.wjgnet.com/2307-8960/full/v10/i23/8097.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i23.8097